SPARC: Supporting Sexual Recovery in Women with Bladder Cancer
Research type
Research Study
Full title
SPARC: Supporting Sexual Recovery in Women with Bladder Cancer
IRAS ID
335939
Contact name
Mieke Van-Hemelrijck
Contact email
Sponsor organisation
Kings College, London
Duration of Study in the UK
4 years, 2 months, 30 days
Research summary
Background & Aims
Bladder cancer is one of the top ten cancers in the UK. In women, it can be more aggressive, meaning it can be more harmful. Bladder cancer often needs invasive treatment or procedures such as bladder removal. This can cause problems with a woman’s sexual well-being and recovery.There are different types of bladder cancer, and each requires a different treatment. In high-risk types, a more intensive treatment is required. The patient may need to have their bladder removed. The bladder is replaced with an alternative option for urine drainage such as a bag on the skin. In bladder removal, evidence tells us that there will be an impact on a woman’s sexual well-being.
Sexual recovery is an important aspect of personal wellbeing and quality of life after cancer treatment. We have worked with women to develop this proposal and they tell us this is important to them.
This study aims to examine this aspect of well-being in women with bladder cancer and having bladder removal. The study will develop a toolkit alongside women to support sexual recovery in this group of patients.
What will the study involve?
The study has been designed in stages to breakdown the individual elements.Stage 1:
The initial stage involves a detailed examination of the existing literature to understand what needs to be discovered.Stage 2:
The next stage requires in-depth investigation through interviewing patients individually or in a group. Doctors and nurses will also be interviewed about sexual well-being and bladder cancer. Findings from these interviews will be looked at to identify common themes and to understand how care is given.Stage 3:
Findings from Stages 1 and 2 will be used to co-design a toolkit. The toolkit will be designed in partnership with patients and clinical experts.It is anticipated that the toolkit will involve education sessions face to face or online to allow the healthcare provider to give better care. The toolkit will be tested to check it is meeting the needs of patients and that it is acceptable to users.
Public Involvement and Engagement
This is a co-design project. This means that patients are involved in the project at every stage. At the start, a project co-design group has been created. This includes five patients with experience of bladder cancer. The group is from different backgrounds and further efforts will be made to include people from under-represented groups. For example, the patient group thought it was important for patients to be offered interviews alone or in groups. This was particularly important for the members from under-represented groups, so the study design was amended.Considerations
Prior to starting, ethical approval will be sought to be sure the study will not cause harm. Patients will be invited to participate by post or email. Participation will be voluntary and can be withdrawn. Recruited patients will be allocated an anonymous identification code and all data will be stored in a safe way.Some participants may feel upset during the study and need extra support. If this happens, they will be referred for specialist help.
Outcomes
A toolkit will be designed for healthcare professionals. The toolkit will help healthcare professionals to support women’s sexual recovery. The toolkit will be tested to make sure it works.The findings will be shared with patients online and through charity groups. This will be achieved through explanatory animations. Doctors and nurses will be encouraged to complete the training and will be alerted to it at professional meetings and groups. The final aim is to include this toolkit within clinical training and guidelines.
REC name
South West - Frenchay Research Ethics Committee
REC reference
25/SW/0061
Date of REC Opinion
18 Jun 2025
REC opinion
Further Information Favourable Opinion